Abiomed (ABMD) Tops Q3 EPS by 16c; Raises Low End of FY Revenues Guidance
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Selling, general and administrative: 53.09M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, general and administrative: 53.09M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q3 EPS of $1.13, $0.16 better than the analyst estimate of $0.97. Revenue for the quarter came in at $261 million versus the consensus estimate of $253.8 million.
GUIDANCE:
Abiomed sees FY2022 revenue of $1.025-1.03 billion, versus the consensus of $1.02 billion.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
